ENLIGHTED: Padeliporfin VTP for Low-Grade Upper Tract Urothelial Carcinoma

Vitaly Margulis, MD, of UT Southwestern Medical Center, and Katie S. Murray, DO, MS, of NYU Langone Urology and Bellevue Hospital, showcase a trial in progress presented at the 2024 American Society of Clinical Oncology Annual Meeting.

ENLIGHTED is phase 3 study examining the efficacy and safety of padeliporfin vascular targeted photodynamic therapy for the treatment of low-grade upper tract urothelial cancer.